Celiac disease has one of the strongest associations with HLA (human leukocyte antigen) class H markers of the known HLA-linked diseases. This association is primarily with the class II serologic specificities HLA-DR3 and -DQw2. We previously described a restriction fragment length polymorphism (RFLP) characterized by the presence of a 4.0-kilobase Rsa I fragment derived from an HLA class II
of celiac disease patients from those of many serologically matched controls. We now report the isolation of this fl-chain gene from a bacteriophage genomic library constructed from the DNA of a celiac disease patient. Based on restriction mapping and differential hybridization with class II cDNA and oligonucleotide probes, this gene was identified as one encoding an HLA-DP fi chain. This celiac disease-associated HLA-DP f-chain gene was flanked by HLA-DP a-chain genes and, therefore, was probably in its normal chromosomal location. The HLA-DP a-chain genes of celiac disease patients also were studied by RFLP analysis; 84% of HLA-DR3, -DQw2 patients had a 16-kb Xba I fragment that was present in only 36% of HLA-DR3, -DQw2 controls. Moreover, 79% of these patients had both a-and fl-chain polymorphisms in contrast to 27% of controls. Thus, celiac disease is associated with a subset of HLA-DR3, -DQw2 haplotypescharacterized byHLA-DP a-and fl-chain gene RFLPs. Within the celiac-disease patient population, the joint segregation of these HLA-DP genes with those encoding the serologic specificities HLA-DR3 and -DQw2 indicates: (i) that the class H HL4 haplotype associated with celiac disease is extended throughout the entire HLA-D region, and (ii) that celiac-disease susceptibility genes may reside as far centromeric on this haplotype as the HLA-DP subregion.
Celiac disease (reviewed in ref. 1 ) is characterized by small intestinal mucosal injury and malabsorption. Disease is activated by the ingestion of dietary wheat gliadins and similar alcohol-soluble proteins, known as prolamins, in other grains. Genetic and environmental factors and immune mechanisms are implicated in the etiology and pathogenesis ofthis disease, but the specific contribution ofeach to disease is not well defined.
Celiac disease, like other human leukocyte antigen (HLA) class II-linked diseases (2) , is primarily associated with a particular HLA-D region haplotype. HLA-D region haplotypes can be identified as cosegregating groups of serologic specificities that are encoded in adjacent class II subregions on a single chromosome. One such haplotype, encoding the serologic specificities HLA-DR3 and -DQw2, is highly represented in the celiac-disease patient population. HLA-DR3 and -DQw2 specificities are found in >80% of all celiacdisease patients (3) (4) (5) . However, they are also present in 25-30%o of apparently healthy Caucasians of Northern European extraction (5), a fact that minimizes their utility as disease-specific markers. Furthermore, the majority of the HLA-DR3, -DQw2 population ingests dietary gluten without the development of disease, indicating that the HLA-DR3, -DQw2 haplotype of celiac-disease patients may be distinct from serologically identical haplotypes found among normal individuals.
We previously reported an HLA class 11 3-chain gene restriction fragment length polymorphism (RFLP) present in 90%o of HLA-DQw2 celiac-disease patients compared to 18% of matched controls (6) . This RFLP was initially detected by hybridization to an HLA-DQ (-chain cDNA probe but did not appear, from the published sequence of a -DQw2 (3-chain gene (7) , to be of HLA-DQ origin. We now describe the isolation of the gene containing this RFLP and its characterization as one encoding an HLA-DP ( chain. We also report a polymorphic HLA-DP a-chain gene, which frequently cosegregates with this (3-chain gene in celiac-disease patients. Together these a-and 3-chain RFLPs define an HLA-DP subregion that distinguishes the HLA-DR3, -DQw2 haplotype of celiac-disease patients from those of most serologically matched controls.
MATERIALS AND METHODS
Construction and Screening of a Bacteriophage A Genomic DNA Library. Celiac-disease patient DNA was purified as described (6) from an Epstein-Barr virus-transformed lymphoblastoid B-cell line (HLA-AI,24; B8; DR3; DQw2). DNA was partially digested with the restriction endonuclease Mbo I, and fragments of 17-23 kilobases (kb) were size-selected by low-melting-point agarose gel electrophoresis. These fragments were ligated to BamHI-, EcoRI-, and alkaline phosphatase-treated EMBL3 bacteriophage X DNA (Promega Biotec, Madison, WI). Ligated DNAs were packaged in vitro, and recombinant phage were selected by infection of the restrictive host Escherichia coli NM539. The resulting library contained >106 recombinant bacteriophage. Phage plaques were screened by plaque-lift hybridization (8) with nick-translated class II HLA gene probes, and hybridizing clones were isolated by three cycles of plaque purification (9) . Isolation of overlapping phage clones was conducted as reported (10) . Recombinant phage DNAs were purified as described (11) .
DNA Blot Hybridization. Southern blot hybridization of genomic DNA was conducted as before (6) . Southern ature and twice for 30 min in 0.1 x SSC/0.1% NaDodSO4 at 60'C. Blots were exposed to Kodak XAR-5 x-ray film with an intensifying screen for 12-72 hr.
Slot blots were prepared with 1:1 serial dilutions of either genomic or phage DNA. DNAs were diluted in 20x SSC, boiled for 5 min, and chilled in ice water. Samples were loaded on nitrocellulose membranes, baked, and hybridized to end-labeled oligonucleotide probes essentially as described (12, 13) .
Hybridization Probes. Probes used in these studies were as follows: a 780-base-pair (bp) Pst I-EcoRI fragment of p1 (3-(14) , an HLA-DQ (3-chain cDNA; a 790-bp Sst 1-HindI1 fragment of p11(3-3 (15) , an HLA-DR 83-chain cDNA; a 600-bp Rsa I-HinclI fragment of p11 (3-7 (16) , an HLA-DP (-chain cDNA; an 800-bp EcoRI fragment of pDAa13B, an HLA-DP a-chain cDNA; and 250-bp and 380-bp Ava I-Sac I fragments of p11(3-1, corresponding to the (3-chain exons 1 and 2, respectively. Probe DNA fragments were isolated by lowmelting-point agarose gel electrophoresis and purified on Elutip-d minicolumns (Schleicher & Schuell) according to the manufacturer's specifications. Fragments were 32P-labeled by nick-translation to specific activities of2-4 x 108 cpmn/,ug.
The HLA-DO (-chain oligonucleotide probe has been described elsewhere (12, 13) . The HLA-DX (-chain oligonucleotide is a 26-mer with the sequence 5'-GCCCTTAAAC-TGAACCAAGAAATCCT-3', which is complementary to the sense orientation of the HLA -DX,(-chain gene exon 1.
Restriction Mapping. Genomic DNA inserts of recombinant bacteriophage were restriction enzyme-mapped by Southern blot hybridization. Recombinant phage DNAs were digested with Sal I, which cleaves in the multiple cloning site of EMBL3, to separate the phage arms from the inserts. Sal I-digested phage DNAs were used in a series of single and double restriction endonuclease digestions. The digests were electrophoresed, blotted to nitrocellulose, and hybridized to their respective purified phage inserts that had been radiolabeled by nick-translation. HLA-DP,8-chain exon locations were determined by hybridizations to probes specific for (-chain exons 1 and 2, to a full-length (-chain cDNA probe (pl(-il), and to the full-length (3-chain cDNA probe lacking the 3' untranslated region (780-bp Pst I-EcoRI fragment of pIl(-i). Restriction fragments containing a-chain-encoding regions were identified by hybridization to a full-length HLA-DP a-chain cDNA probe. To permit normalization of these signals, lanes in each of the three blots in Fig. 2A also had been loaded with equal amounts of plasmid containing HLA-DQ, -DR, and -DP ,8-chain cDNAs. The hybridization of these plasmids to the respective cDNA probes is shown in Fig. 2B . When the blots were hybridized to the HLA-DQ cDNA insert probe (Fig.  2B) , the strongest signal was obtained with the HLA-DQ plasmid (pII,3-1) as target DNA. This probe hybridized less well to the HLA-DR plasmid (pII3,-3) and least of all to the HLA-DP plasmid (pI, (3-7) . Similarly, the HLA-DR cDNA insert probe (Fig. 2B) hybridized most strongly to the HLA-DR plasmid, less well to the HLA-DQ plasmid, and least of all to the HLA-DP plasmid. The HLA-DP cDNA insert probe (Fig. 2B) hybridized strongest to the HLA-DP plasmid and less so but equally well to the HLA-DR and -DQ plasmids. In each case the intensities of hybridization were those expected, given the reported homologies between these three (-chain genes (17) . Note, too, that the intensities of the homologous probe/plasmid combinations were approximately equal. Together these data indicate that the results in Fig.  2A reflect relative homologies between the X321 (-chain and HLA-DP, -DQ, and -DR cDNAs. It was concluded from this analysis that X321 likely contained an HLA-DP (3-chain gene.
Restriction Mapping of A321. To confirm the identification of the X321 gene as one encoding an HLA-DP (3-chain, a restriction map of the 321 insert was constructed (Fig. 3A) . This map is remarkably similar to previously published maps of HLA-DP (3-chain gene 1 (designated HLA-DPIB) isolated from two different -DP4-typed cell lines (18, 19) and is virtually identical to that reported for an HLA-DPIB gene isolated from an HLA-DP3-typed cell line (19) . This identity with published restriction maps confirms the identification of the gene in X321 as an HLA-DP P-chain gene. Furthermore, it shows it to be the HLA-DPIB gene that encodes HLA-DP membrane molecules and not the HLA-DP 13-chain pseudogene 2 (designated HLA-DP2B).
The HLA-DPIB gene has been shown in previous studies to be flanked by HLA-DP a-chain genes HLA-DPIA and HLA-DP2A (pseudogene) (18) (19) (20) (21) . HLA-DP a-chain region is present in a 1.9-kb HindIII-Sal I fragment of A321 3' of the HLA-DPIB gene (Fig. 3A) . This likely represents a portion of the HLA-DP2A pseudogene. DNA 5' of the X321 «3-chain gene was analyzed through the isolation of overlapping phage clones. A restriction map of one ofthese clones, X2k, is shown in Fig. 3B . This clone extends 11 kb 5' of X321 and contains HLA-DP a-chain-encoding region in a 4.8-kb BamHI fragment. This is similar to the BamHI fragment shown by Gorski et al. (21) to contain the coding HLA-DPIA gene. That the restriction maps of X321 and X2k are in agreement with previously published maps of the HLA-DP subregion demonstrates that the (3-chain gene found in the celiac-disease patient population is the coding HLA-DPJB gene and that it is probably in its normal chromosomal location.
HLA-DP a-Chain Gene RFLP Analysis. To further define the HLA-DP genes of celiac-disease patients, we examined HLA-DP a-chain gene polymorphisms using patient and control DNA pools as described (22 selected healthy Caucasians, 33% (14/43) had the a-chain RFLP, 44% (19/43) had the P-chain RFLP, and 19o (8/43) had the combination of the two. Thus, among HLA-DR3, -DQw2 individuals, a population already at significant risk for the development ofceliac disease (3) (4) (5) , the presence ofthese HLA-DP a-and ,B-chain RFLPs increases that risk by a factor of 10 (X2 = 7.75; P < 0.01). DISCUSSION This report describes a significant association between celiac disease and a pair of HLA-DP a-and (3-chain gene RFLPs. Both of these RFLPs are highly represented in HLA-DR3, -DQw2 celiac disease patients when compared to either HLA-DR3, -DQw2 or non-DR3, non-DQw2 controls. These RFLPs allow us to distinguish a particular HLA-DR3, -DQw2 haplotype that is associated more strongly with celiac disease than serologically identical haplotypes found in many normal individuals. Furthermore, the cosegregation of these RFLPs with the HLA-DR3 and HLA-DQw2 serologic specificities is indicative of an extended haplotype comprised of the subregions encoding the HLA-DR3, -DQw2 serologic specificities and each of these HLA-DP a-and p-chain RFLPs and suggests that these HLA-DP genes are located on a single chromosome in the same HLA-DP subregion. The cosegregation of a particular HLA-DP subregion with the subregions encoding the HLA-DR3 and -DQw2 specificities is somewhat unexpected. HLA-DR and -DQ specificities are encoded in tightly linked class II subregions that have not been shown to undergo recombination (23) . However, recombination between these two subregions and the HLA-DP subregion is well-documented (24) and has been estimated to (25) . Therefore, a given HLA-DR haplotype would not be expected to associate preferentially with a particular HLA-DP subregion as does the HLA-DR3 haplotype of celiac-disease patients.
The frequency with which the celiac-disease HLA-DP subregion can associate with any given HLA-DR haplotype can be estimated from our analysis of a normal random control population. Approximately 20%o of these individuals possess Therefore, at most, one in five individuals may inherit this HLA-DP subregion as a consequence of normal recombinational events within the general population. A similar frequency (27%) was observed for the HLA-DR3, -DQw2 control population, suggesting that the haplotypes of these individuals are not unlike other HLA-DR haplotypes regarding their association with this HLA-DP subregion. In contrast, =8M% of HLA-DR3, -DQw2 celiac disease patients have this HLA-DP subregion. One explanation is that the frequency of HLA-DR/ -DP recombination on the celiac disease-associated-DR3, -DQw2 haplotype is significantly less than the recombination frequencies of other haplotypes in the general population. Thus, the strong linkage disequilibrium normally observed between the HLA-DR and -DQ subregions would be extended, on this haplotype, throughout the entire HLA-D region. The celiac disease-associated HLA-DR3 haplotype was recently shown to be extended telomerically from the subregion encoding HLA-DR3 through the genes encoding the complotype SC01 to the HLA-B8 locus (26) . Similarly, our findings indicate that this HLA-DR3, -DQw2 haplotype may have an unusual degree of linkage disequilibrium, extending centromerically from the HLA-DR subregion to the HLA-DP subregion.
Alternatively, the cosegregation of these HLA-DP, -DQ, and -DR subregions among celiac-disease patients may not reflect positive linkage disequilibrium between HLA-DR and -DP. Rather, the HLA susceptibility of celiac disease may be multigenic, with, for example, obligatory roles for HLA-DP and -DQ or -DR genes. A multigenic disease mechanism, predictably, would produce results similar to those reported herein: increased frequencies of multiple HLA-D markers within the patient population. However, such cosegregation would result, not from a decreased recombination frequency between the relevant markers but through selection by the disease for the unrecombined or reassociated haplotype.
Whether or not the HLA-DP subregion genes contribute to celiac-disease susceptibility cannot be determined from this study. The HLA-DP ,/-chain gene RFLP is associated with disease to nearly the same degree as HLA-DR3 and -DQw2 specificities; only one patient in this sampling lacked the HLA-DPl-chain gene polymorphism. The HLA-DP a-chain gene RFLP also is strongly associated with disease in -DR3, -DQw2 individuals, but to a lesser degree than the /3-chain gene RFLP, suggesting that if a susceptibility gene resides in this subregion, it is more likely the latter. Alternatively, the HLA-DP genes identified in this study may not be directly involved in celiac-disease susceptibility. Rather, they may be markers of an extended haplotype in linkage disequilibrium with susceptibility genes located elsewhere on the haplotype.
Clearly, molecular genetic strategies are useful in accurately defining HLA haplotypes that predispose for disease. A unique HLA-DR3 haplotype, associated with myasthenia gravis, has been identified by virtue of an HLA-DQ /3-chain gene RFLP (27) . Similarly, insulin-dependent diabetes mellitus (22, (28) (29) (30) (31) (32) and rheumatoid arthritis (29, 33) have been correlated with subsets of HLA-DR4 haplotypes that can be distinguished by genetic heterogeneity among HLA-DR and/ or -DQ genes. The present report demonstrates that HLA-DP markers also are useful in distinguishing among serologically identical HLA haplotypes. Further molecular analysis of HLA-DP specificities will facilitate a better understanding of HLA genetics and class II-associated disease.
